Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Carboplatin 15Paclitaxel 13Hyperthermic Intraperitoneal Chemotherapy 6Cisplatin 5olaparib 4niraparib 4Bevacizumab 4oregovomab 3Topotecan 3Immunohistochemistry 3Gemcitabine 3Drug Therapy 3Docetaxel 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Amplified Fragment Length Polymorphism Analysis 3pembrolizumab 2liposomal doxorubicin 2anlotinib 2ST 1481 2Radiotherapy 2Polymerase Chain Reaction 2Oxaliplatin 2Neoadjuvant Therapy 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Diathermy 2Cytoreduction Surgical Procedures 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Ovarian Epithelial × Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization × Clear all
NCT00238342 2010-02-09

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

National Cancer Institute (NCI)

Phase NA Unknown
2,000 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡